We are all trying to do our best for our patients. Yet, almost a decade after the International League Against Epilepsy celebrated its centenary, untreated epilepsy continues to thrive. Efforts are made, plans are formulated, money is being spent. However, the treatment gap data from middle and low-income countries remains dismal [1] . We may claim small successes here and there, but we have to accept that there are serious flaws in how we have visualized the problem and the route we have chosen to solve it. Where have we gone wrong?
Unfortunately, the bulk of epilepsy, roughly 70% of all cases, falls in the proverbial 'no man's land'! That, to me, is the single biggest obstacle that gets in the way of moving forward. For experts, this kind of epilepsy seems rather mundane: all you need to do is make a diagnosis, choose and start one appropriate antiepileptic drug and then continue it for a few years. The non-specialist encounters this kind of epilepsy that should be easy to treat, but to himall epilepsy looks quite alike. He thinks he does not possess the wherewithal to deal with it. He is not a specialist. To a large extent, at least in the Indian context, I empathize with the non-specialist. Most have not been trained well enough to be confident in their management of epilepsy. The result of this kind of uncertainty and confusion is what we have on our hands today. In India, I have personal experience of regularly finding hundreds of people with epilepsy every month who are getting no treatment. And, I am certain that the numbers that I continue to see are just the tip of a huge iceberg that is lurking out there.
And what do we do for the 30% of patients whose epilepsy is difficult to treat? We often have experts pore over the literature looking for answers. Money is invested in finding that new drug which may control one or two more seizures than the previous ones. Devices, surgeries, robotics; we want to leave no stone unturned. Epilepsies for which we do not yet have perfect treatment deserve our attention and our resources. They get both. We talk ad nauseam about them in our conferences; write reams about them in our research papers. Funders are sympathetic and loosen their purse strings when they are mentioned. After all, we are on a scientific voyage to find a cure for something that has evaded our heroic efforts for decades. This is a challenging and exciting endeavor holding much promise.
That brings us back to the 70% of people with epilepsy who have been all but forgotten. Their seizures constitute the 'low hanging fruit' of epilepsy. Ironically, this is also the 'elephant in the room' that we do not stop to look at or ponder over! Who is taking care of these patients? Have we trained enough primary or secondary epilepsy care providers to meet the needs of millions of these easy-to-treat epilepsy patients? Are we disseminating enough information to make our communities and patients 'epilepsy literate'? Have we found a way to ensure that an uninterrupted supply of antiepileptic drugs is available to these patients at a cost that they can afford? How many of these patients are dying every year because of uncontrolled, untreated epilepsy? How many are getting maimed, mutilated, and disfigured such as the woman in Fig. 1 ? We do not know.
Our resources are extremely limited and spread thinly. In the current issue of Seizure, Singh et al. point out that arranged marriages continue to be common across Asia and that the effects of epilepsy on people's marriage prospects has not received sufficient attention from researchers [2] . If we lived in a utopian world, I would say let every epilepsy patient not just get treatment to stop her seizures but look at her as a whole person. Attend to all complications that arise as a consequence of epilepsy intersecting with her life and the lives of those around her. Ensure she does not miss out on education, a profession, her goals and dreams. Let epilepsy not compel her to lead a stigmatized life of shame and despair. Let it not come in the way of her friendships, her relationships. Let it not come in the way of her living, as a human should. Let everything be perfect. Alas, we are not in that world yet. The lives of millions of people with epilepsy who live in low and middle-income countries are very far from this utopia. There is no respite for them. Their immediate need is that somebody should please stop their seizures. They have waited for decades; no help seems to be in sight.
While people with epilepsy face a very different basic reality, we have to continue making those important decisions about how and where we allocate further resources. What do we put our minds to, how best to use the limited time available to us and where do we put our money? There is scope to improve every aspect of epilepsy care. There is scope to research and further understand every aspect of epilepsy. However, if we insist that overcoming obstacles in the way of successful marital relationships is as important as instituting antiepileptic drug treatment in a young woman with epilepsy who has never been treated, then we are resorting to false equivalence. We are trying to embellish a princess who has no clothes! It is a futile exercise.
There may be differing views on what should be the driving force behind epilepsy research. All researchers aim to advance science and improve our understanding of mechanisms of diseases and their treatments. Ultimately researchers strive to ensure that the lives of patients benefit from their work. Ideal research has to be contextual, relevant and have translational value. This becomes even more urgent if research is reliant on resources that are scarce and are being diverted from another potential area of research that may hold the promise of being more transformative for patients' lives. Epilepsy research conducted in a society where most people with epilepsy receive appropriate antiepileptic drug treatment will expand to other important epilepsy-related issues. These may include the study of the patterns of relationships in epilepsy patients and how having epilepsy may influence these. A better understanding in this sphere may help patients negotiate issues related to marriage in a better, more informed way. Ultimately, such research is likely to improve the quality of life of the patient. However, is there a point of trying to look at variables influencing marital outcomes in a patient who is having frequent seizures and has never been on appropriate antiepileptic drug treatment? Would it not be more impactful to look for a way to secure access to treatment for all such people first?
I sometimes wonder if epilepsy experts in low and middle-income countries are at least partly responsible for the state of epilepsy care in our regions. This may sound provocative, but if it shakes some of us out of our reverie, it would have served its purpose. Epilepsy experts may not be aware of it, but they wield power. They decide what will be made 'visible'. They set the tone, frame the narrative, and prioritize agenda. Junior colleagues, trainees, other doctors look to them for direction and inspiration. One has only to look at the scientific programs of important national and international epilepsy meetings of the last 10 years to see what we are preoccupied with. A similar audit of epilepsy research being done at the moment will reveal the direction that we are moving in. Where is the big money being invested? Are we looking at ways to improve access to care? Have we tried to understand the nuances of what lies at the core of a secondary treatment gap? These questions are unique to our patients. They will have to be answered by us. As long as we remain focused only on the 30% of cases of epilepsy, the condition of the remaining 70% will remain unchanged. In all our efforts, including the conduct of epilepsy research, let us try to remain connected and cognizant of the failures of our system and find ways to correct them.
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Department of Neurology, All India Institute of Medical Sciences, New Delhi 110029, India E-mail address: mbsneuro@gmail.com Fig. 1 . 28-year old woman with focal epilepsy. Symptomatic for 13 years and never treated with antiepileptic drugs. She was burnt during a recent seizure whilst cooking for the family. She presented to the plastic surgery department for skin grafting and was referred to Neurology department at All India Institute of Medical Sciences to start treatment for epilepsy.
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